Register
Medicines reference
Product

Keppra

Levetiracetam · UCB, UCB / GlaxoSmithKline, UCB Pharma

4 forms: coated tablet, solution, tablet. No registration in force in Georgia.

Forms and doses0 of 4 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Used for: Epilepsy

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
100 mg/ml, Solution · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
· every 8 hours
every 8 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 100მგ/მლ ორალური ხსნარი 300მლ ფლაკონი #1
Verified on: 29 Oct 2026
100 mg/ml, Solution · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
· every 8 hours
every 8 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 100მგ/მლ ორალური ხსნარი 300მლ ფლაკონი #1
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Keppra 100 mg/ml, Solution

oral solution, human medicine
Composition / strength
Levetiracetam100 mg/ml
Formulation Type
Solution
Administration route
By mouth
Manufacturer
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 100მგ/მლ ორალური ხსნარი 300მლ ფლაკონი #1
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.
250 mg, Coated tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
· every 8 hours
every 8 hours Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 250მგ შემოგარსული აბი
№ რ-021399
Verified on: 29 Oct 2026
250 mg, Coated tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
· every 8 hours
every 8 hours Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 250მგ შემოგარსული აბი
№ რ-021399
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Keppra 250 mg, Coated tablet

film-coated tablet, human medicine
Composition / strength
Levetiracetam250 mg
Formulation Type
Coated tablet
Administration route
By mouth
Registration
Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 250მგ შემოგარსული აბი
№ რ-021399
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.
500 mg, Coated tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
· every 8 hours
every 8 hours Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 500მგ შემოგარსული აბი
№ რ-021400
Verified on: 29 Oct 2026
500 mg, Coated tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
· every 8 hours
every 8 hours Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 500მგ შემოგარსული აბი
№ რ-021400
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Keppra 500 mg, Coated tablet

film-coated tablet, human medicine
Composition / strength
Levetiracetam500 mg
Formulation Type
Coated tablet
Administration route
By mouth
Registration
Georgia Expired
Expired on 06 Sep 2020, not renewed yet
Human (Ministry of Health, RAMA)
In the register: კეპრა 500მგ შემოგარსული აბი
№ რ-021400
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.
1000 mg, Tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
· every 8 hours
every 8 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 1000მგ აბი - #50
Verified on: 29 Oct 2026
1000 mg, Tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
· every 8 hours
every 8 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 1000მგ აბი - #50
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Keppra 1000 mg, Tablet

tablet, human medicine
Composition / strength
Levetiracetam1000 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: კეპრა 1000მგ აბი - #50
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.

Known Contraindications

  • Warning
    Phenobarbital speeds levetiracetam clearance (lower peaks, faster elimination); dogs on phenobarbital may need a higher dose, guided by serum levels.
    Sources: ACVIM · JVIM
  • Warning (Dog)
    Intravenous levetiracetam: dilute and give slowly. A rapid undiluted 60 mg/kg bolus caused tachycardia, hypotension, hyperglycaemia and dull mentation in a dog.

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.